Nikola Sozańska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nikola Sozańska has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Andrzej Ożyhar
Department of Biochemistry, Molecular Biology and Biotechnology, Faculty of Chemistry, Wrocław University of Science and Technology, Wrocław, Poland
3 shared publications - Aneta Tarczewska
Department of Biochemistry, Molecular Biology and Biotechnology, Faculty of Chemistry, Wroclaw University of Science and Technology, Wroclaw, Poland
3 shared publications - Anna Niedzwiecka
Laboratory of Biological Physics, Institute of Physics, Polish Academy of Sciences, Aleja Lotnikow 32/46, PL-02668 Warsaw, Poland
3 shared publications - Barbara Paulina Klepka
Laboratory of Biological Physics, Institute of Physics, Polish Academy of Sciences, Aleja Lotnikow 32/46, PL-02668, Warsaw, Poland
3 shared publications - Beata Greb-Markiewicz
Department of Biochemistry, Molecular Biology and Biotechnology, Faculty of Chemistry, Wroclaw University of Science and Technology, Wybrzeże Wyspiańskiego 27, 50-370, Wroclaw, Poland
3 shared publications - Liliya Zhukova
Institute of Biochemistry & Biophysics, Polish Academy of Science, Warsaw, Poland
1 shared publication
Latest Publications
- 7 May 2026
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 782, 110829
Intrinsically disordered bHLH family member TCF4 drives phase separation in a DNA-dependent manner
- 7 May 2026
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 782, 110829
Intrinsically disordered bHLH family member TCF4 drives phase separation in a DNA-dependent manner
- Open Access
Intrinsically disordered bHLH family member TCF4 drives LLPS in a DNA-dependent manner
Transcription factor 4 (TCF4), a basic helix-loop-helix (bHLH) protein, plays a critical role in neurodevelopment and is genetically linked to disorders such as Pitt-Hopkins syndrome (PTHS) and schizophrenia. While TCF4 is known to function through sequence-specific DNA binding, the influence of its intrinsically disordered regions (IDRs) on its molecular behavior remains scattered. The TCF4 deletion mutant, lacking a fragment of the bHLH domain, forms puncta in the nucleus, which are reminiscent of patterns observed in disease-associated TCF4 mutants. Our in vitro analyses have demonstrated that the shortest human isoform of TCF4 (TCF4-I − ), which is predominant in the brain and contains extensive IDRs, undergoes liquid-liquid phase separation (LLPS) in vitro . LLPS is promoted by increased ionic strength and molecular crowding, resulting in dynamic, liquid-like condensates that coalesce and display rapid fluorescence recovery after photobleaching (FRAP). Over time, these condensates mature, exhibiting increased viscosity while retaining molecular mobility. Importantly, we show that both specific and non-specific DNA sequences dissolve TCF4 condensates. This suggests that DNA binding competitively inhibits the multivalent interactions necessary for phase separation. These findings indicate that LLPS driven by TCF4 is a reversible process, likely involved in transcriptional activation bursts. We propose that mutations that disrupt DNA binding or localization may trap TCF4 in aberrant condensates, contributing to PTHS pathogenesis through dysregulated phase behavior. Our findings offer a mechanistic link between TCF4 structural features, phase separation, and its transcriptional function, providing novel insight into how mutations in this TF may drive neurological disease through aberrant biomolecular condensation.
Open AccessIntrinsically disordered bHLH family member TCF4 drives LLPS in a DNA-dependent manner
Transcription factor 4 (TCF4), a basic helix-loop-helix (bHLH) protein, plays a critical role in neurodevelopment and is genetically linked to disorders such as Pitt-Hopkins syndrome (PTHS) and schizophrenia. While TCF4 is known to function through sequence-specific DNA binding, the influence of its intrinsically disordered regions (IDRs) on its molecular behavior remains scattered. The TCF4 deletion mutant, lacking a fragment of the bHLH domain, forms puncta in the nucleus, which are reminiscent of patterns observed in disease-associated TCF4 mutants. Our in vitro analyses have demonstrated that the shortest human isoform of TCF4 (TCF4-I − ), which is predominant in the brain and contains extensive IDRs, undergoes liquid-liquid phase separation (LLPS) in vitro . LLPS is promoted by increased ionic strength and molecular crowding, resulting in dynamic, liquid-like condensates that coalesce and display rapid fluorescence recovery after photobleaching (FRAP). Over time, these condensates mature, exhibiting increased viscosity while retaining molecular mobility. Importantly, we show that both specific and non-specific DNA sequences dissolve TCF4 condensates. This suggests that DNA binding competitively inhibits the multivalent interactions necessary for phase separation. These findings indicate that LLPS driven by TCF4 is a reversible process, likely involved in transcriptional activation bursts. We propose that mutations that disrupt DNA binding or localization may trap TCF4 in aberrant condensates, contributing to PTHS pathogenesis through dysregulated phase behavior. Our findings offer a mechanistic link between TCF4 structural features, phase separation, and its transcriptional function, providing novel insight into how mutations in this TF may drive neurological disease through aberrant biomolecular condensation.
- Open Access
- 27 March 2025
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 23 (1) , 1-20
The molecular properties of the bHLH TCF4 protein as an intrinsically disordered hub transcription factor
Background: Transcription factor 4 (TCF4) is a member of the basic helix-loop-helix (bHLH) family of transcription factors that guides proper embryogenesis, particularly neurogenesis, myogenesis, heart development and hematopoiesis. The interaction of TCF4 with DNA is dependent on the presence of a conserved bHLH domain, particularly the presence of a basic (b) motif. Most mutations in the Tcf4 gene are either associated with the development of serious nervous system disorders, such as Pitt-Hopkins syndrome or schizophrenia, or are lethal. Although TCF4 is essential for the proper development and function of the human body, there is a lack of fundamental knowledge about the structure of TCF4 since structural studies were previously limited exclusively to its bHLH. Methods: Recombinant full-length TCF4 was expressed in bacterial cells and purified using chromatographic techniques. To compare the properties of TCF4 in its apo and holo form, we determined the dissociation constant (KD) of the TCF4:DNA complex using independent methods, including fluorescence polarization (FP), electrophoretic mobility shift assay (EMSA), and fluorescence correlation spectroscopy (FCS). Then we compared the properties of TCF4 in its apo and holo form in relation to the changes of the conformation of the polypeptide chain (hydrogen/deuterium exchange mass spectrometry; HDX-MS), hydrodynamic properties (e.g., sedimentation-velocity analytical ultracentrifugation; SV-AUC), and stability (thermal shift, circular dichroism; CD). Results: We demonstrate the molecular characteristics of TCF4, the dimer of which is one of the largest intrinsically disordered proteins (IDPs) described to date. According to our findings, the structure of TCF4 is extensively disordered. Only the bHLH domain exhibits a stable fold. Strikingly, Ephrussi-box (E-box) binding via the bHLH domain has no significant effect on the disordered nature of TCF4, but it does influence the dynamic of bHLH and stability of the protein. Conclusions: We suggest that bHLH plays the role of an anchor localizing TCF4 to specific gene sequences. The dual nature of the TCF4 structure and the fact that the intrinsically disordered regions (IDRs) represent most of the protein sequence, suggest that TCF4 may act as a hub transcription factor regulating the expression of specific genes through the interaction of IDRs with gene-specific partners.
- 27 March 2025
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 23 (1) , 1-20
Open AccessThe molecular properties of the bHLH TCF4 protein as an intrinsically disordered hub transcription factor
Background: Transcription factor 4 (TCF4) is a member of the basic helix-loop-helix (bHLH) family of transcription factors that guides proper embryogenesis, particularly neurogenesis, myogenesis, heart development and hematopoiesis. The interaction of TCF4 with DNA is dependent on the presence of a conserved bHLH domain, particularly the presence of a basic (b) motif. Most mutations in the Tcf4 gene are either associated with the development of serious nervous system disorders, such as Pitt-Hopkins syndrome or schizophrenia, or are lethal. Although TCF4 is essential for the proper development and function of the human body, there is a lack of fundamental knowledge about the structure of TCF4 since structural studies were previously limited exclusively to its bHLH. Methods: Recombinant full-length TCF4 was expressed in bacterial cells and purified using chromatographic techniques. To compare the properties of TCF4 in its apo and holo form, we determined the dissociation constant (KD) of the TCF4:DNA complex using independent methods, including fluorescence polarization (FP), electrophoretic mobility shift assay (EMSA), and fluorescence correlation spectroscopy (FCS). Then we compared the properties of TCF4 in its apo and holo form in relation to the changes of the conformation of the polypeptide chain (hydrogen/deuterium exchange mass spectrometry; HDX-MS), hydrodynamic properties (e.g., sedimentation-velocity analytical ultracentrifugation; SV-AUC), and stability (thermal shift, circular dichroism; CD). Results: We demonstrate the molecular characteristics of TCF4, the dimer of which is one of the largest intrinsically disordered proteins (IDPs) described to date. According to our findings, the structure of TCF4 is extensively disordered. Only the bHLH domain exhibits a stable fold. Strikingly, Ephrussi-box (E-box) binding via the bHLH domain has no significant effect on the disordered nature of TCF4, but it does influence the dynamic of bHLH and stability of the protein. Conclusions: We suggest that bHLH plays the role of an anchor localizing TCF4 to specific gene sequences. The dual nature of the TCF4 structure and the fact that the intrinsically disordered regions (IDRs) represent most of the protein sequence, suggest that TCF4 may act as a hub transcription factor regulating the expression of specific genes through the interaction of IDRs with gene-specific partners.